{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-017667","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2022-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.945762+00:00","generated_at":"2026-06-26T09:42:29.355998+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Oramed Pharmaceuticals appoints Yadin Rozov to board of directors","bullets":["Board size increased by one and Yadin Rozov appointed effective April 1, 2022.","Rozov has over 20 years experience in capital markets, corporate finance, and investment banking.","He is founder and managing partner of Terrace Edge Ventures LLC since January 2022.","Rozov previously served as Partner at GoldenTree Asset Management and CEO of Syncora Guarantee.","He will receive the same compensation as other non-executive directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-017667","json":"https://secwatch.observer/filing/0001213900-22-017667.json","markdown":"https://secwatch.observer/filing/0001213900-22-017667.md","text":"https://secwatch.observer/filing/0001213900-22-017667.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022017667/0001213900-22-017667-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022017667/ea157933-8k_oramedphar.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T09:42:29.355998+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"de61303561","claim":"Yadin Rozov was appointed as director at ORAMED PHARMACEUTICALS INC..","evidence_excerpt":"On March 30, 2022, Oramed Pharmaceuticals Inc. (the “Company”) increased the size of its Board of Directors (the “Board”) by one and appointed Mr. Yadin Rozov to serve as a director to fill the resulting vacancy, effective as of April 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022017667/0001213900-22-017667-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}